| Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study G Cavalli, G De Luca, C Campochiaro, E Della-Torre, M Ripa, D Canetti, ... The Lancet Rheumatology 2 (6), e325-e331, 2020 | 1053 | 2020 |
| Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer E Bajetta, I Floriani, M Di Bartolomeo, R Labianca, A Falcone, ... Annals of oncology 25 (7), 1373-1378, 2014 | 107 | 2014 |
| Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: a phase II randomised trial M Reni, S Cereda, M Milella, A Novarino, A Passardi, A Mambrini, ... European Journal of Cancer 49 (17), 3609-3615, 2013 | 105 | 2013 |
| Prognostic factors for survival in metastatic renal cell carcinoma: retrospective analysis from 109 consecutive patients G Citterio, A Bertuzzi, M Tresoldi, L Galli, G Di Lucca, U Scaglietti, ... European urology 31 (3), 286-291, 1997 | 96 | 1997 |
| Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial S De Placido, C Gallo, M De Laurentiis, G Bisagni, G Arpino, MG Sarobba, ... The Lancet Oncology 19 (4), 474-485, 2018 | 82 | 2018 |
| Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet … G Cavalli, G De Luca, C Campochiaro, E Della-Torre, M Ripa, D Canetti, ... Annals of Palliative Medicine. All rights reserved. Ann Palliat Med 10 (1 …, 2021 | 47 | 2021 |
| Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support–free days in patients hospitalized with COVID-19: a randomized … S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, K Fareed, ... Jama 329 (14), 1183-1196, 2023 | 28 | 2023 |
| Treatment of advanced renal cell cancer with sequential intravenous recombinant interleukin-2 and subcutaneous α-interferon C Besana, A Borri, E Bucci, G Citterio, G Di Lucca, C Fortis, P Matteucci, ... European Journal of Cancer 30 (9), 1292-1298, 1994 | 27 | 1994 |
| Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19 SL Calvisi, GA Ramirez, M Scavini, V Da Prat, G Di Lucca, A Laurenzi, ... Metabolism 123, 154845, 2021 | 26 | 2021 |
| A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients D Palumbo, A Zangrillo, A Belletti, G Guazzarotti, MR Calvi, F Guzzo, ... Journal of Critical Care 66, 14-19, 2021 | 22 | 2021 |
| Six‐month respiratory outcomes and exercise capacity of COVID‐19 acute respiratory failure patients treated with continuous positive airway pressure S Damanti, GA Ramirez, EP Bozzolo, P Rovere‐Querini, R De Lorenzo, ... Internal Medicine Journal 51 (11), 1810-1815, 2021 | 17 | 2021 |
| Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19 GA Ramirez, EP Bozzolo, A Gobbi, E Castelli, C Centurioni, M Di Meo, ... Panminerva Medica 64 (4), 506-516, 2022 | 14 | 2022 |
| Impact on survival of timing and duration of adjuvant chemotherapy in radically resected gastric cancer M Di Bartolomeo, F Pietrantonio, E Rulli, D Poli, R Berenato, M Caporale, ... Tumori Journal 102 (4), e15-e19, 2016 | 12 | 2016 |
| Discontinuation of bevacizumab and FOLFIRI administered up to a maximum of 12 cycles as first-line therapy for metastatic colorectal cancer: a retrospective Italian study G Rosati, S Cordio, G Aprile, A Butera, A Avallone, G Di Lucca, F De Pauli, ... Investigational new drugs 30, 1978-1983, 2012 | 10 | 2012 |
| Maintenance sunitinib (MS) or observation (O) in metastatic pancreatic adenocarcinoma (MPA): Clinical and translational results of a phase II randomized trial (NCT00967603). M Reni, S Cereda, M Milella, A Novarino, A Passardi, A Mambrini, ... Journal of Clinical Oncology 30 (15_suppl), 4017-4017, 2012 | 7 | 2012 |
| Isolated left ventricular filling abnormalities may predict interleukin-2-induced cardiovascular toxicity G Citterio, G Fragasso, E Rossetti, G Di Lucca, E Bucci, M Foppoli, ... Journal of Immunotherapy 19 (2), 134-141, 1996 | 7 | 1996 |
| Autoimmune thyroiditis following interleukin-2 and LAK cell therapy for metastatic renal cell carcinoma: correlation with tumor regression C Besana, MG Sabbadini, C Corti, G Di Lucca, M Foppoli, M Marcatti, ... Tumori Journal 77 (4), 339-342, 1991 | 7 | 1991 |
| Intravenous vitamin C for patients hospitalized with COVID-19: two harmonized randomized clinical trials S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, K Fareed, ... JAMA 330 (18), 1745-1759, 2023 | 6 | 2023 |
| A novel evidence-based algorithm to predict thromboembolism in patients with COVID-19: preliminary data from a single-center cohort. GA Ramirez, SL Calvisi, R De Lorenzo, V Da Prat, G Borio, G Gallina, ... Minerva Med, 695-706, 2022 | 6 | 2022 |
| Frailty as a predictor of mortality in COVID-19 patients receiving CPAP for respiratory insufficiency S Damanti, GA Ramirez, EP Bozzolo, V Da Prat, G Di Lucca, G Di Terlizzi, ... Aging clinical and experimental research 34 (4), 945-949, 2022 | 4 | 2022 |
